Bourne Lent Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.47M Buy
14,206
+150
+1% +$34.9K 1.28% 18
2025
Q4
$2.91M Sell
14,056
-130
-0.9% -$25.7K 0.96% 21
2025
Q3
$2.63M Sell
14,186
-45
-0.3% -$7.71K 0.93% 23
2025
Q2
$2.17M Sell
14,231
-20
-0.1% -$3.07K 0.84% 24
2025
Q1
$2.36M Sell
14,251
-115
-0.8% -$18K 1.01% 21
2024
Q4
$2.08M Buy
14,366
+200
+1% +$31K 0.79% 24
2024
Q3
$2.3M Buy
14,166
+50
+0.4% +$7.97K 0.87% 20
2024
Q2
$2.06M Sell
14,116
-225
-2% -$33.5K 0.79% 20
2024
Q1
$2.27M Hold
14,341
0.91% 21
2023
Q4
$2.25M Hold
14,341
0.91% 19
2023
Q3
$2.23M Hold
14,341
0.98% 19
2023
Q2
$2.37M Sell
14,341
-125
-0.9% -$20.2K 0.83% 20
2023
Q1
$2.24M Hold
14,466
0.85% 20
2022
Q4
$2.56M Sell
14,466
-1,040
-7% -$180K 1.1% 20
2022
Q3
$2.53M Hold
15,506
1.1% 20
2022
Q2
$2.75M Sell
15,506
-200
-1% -$35.6K 1.09% 19
2022
Q1
$2.78M Sell
15,706
-50
-0.3% -$8.51K 0.87% 20
2021
Q4
$2.69M Hold
15,756
0.72% 20
2021
Q3
$2.54M Sell
15,756
-100
-0.6% -$17.1K 0.73% 21
2021
Q2
$2.61M Hold
15,856
0.73% 22
2021
Q1
$2.61M Buy
15,856
+60
+0.4% +$9.71K 0.83% 19
2020
Q4
$2.49M Sell
15,796
-320
-2% -$47.2K 0.82% 19
2020
Q3
$2.4M Hold
16,116
0.92% 18
2020
Q2
$2.27M Hold
16,116
0.98% 16
2020
Q1
$2.11M Sell
16,116
-535
-3% -$75.9K 1.13% 16
2019
Q4
$2.43M Hold
16,651
1.14% 16
2019
Q3
$2.15M Sell
16,651
-50
-0.3% -$6.59K 1.03% 17
2019
Q2
$2.33M Hold
16,701
1.12% 15
2019
Q1
$2.33M Hold
16,701
1.16% 16
2018
Q4
$2.15M Buy
16,701
+505
+3% +$70.4K 1.28% 16
2018
Q3
$2.24M Hold
16,196
1.07% 17
2018
Q2
$1.97M Sell
16,196
-350
-2% -$43.7K 1.04% 18
2018
Q1
$2.12M Sell
16,546
-420
-2% -$56.8K 1.15% 16
2017
Q4
$2.37M Buy
16,966
+960
+6% +$134K 1.28% 16
2017
Q3
$2.08M Buy
16,006
+126
+0.8% +$16.7K 1.07% 16
2017
Q2
$2.1M Sell
15,880
-750
-5% -$95.7K 1.15% 15
2017
Q1
$2.07M Sell
16,630
-735
-4% -$87.8K 1.13% 16
2016
Q4
$2M Buy
17,365
+3,535
+26% +$408K 1.19% 17
2016
Q3
$1.63M Hold
13,830
1.2% 14
2016
Q2
$1.68M Hold
13,830
1.32% 15
2016
Q1
$1.5M Hold
13,830
1.2% 15
2015
Q4
$1.42M Sell
13,830
-400
-3% -$40.2K 1.08% 15
2015
Q3
$1.33M Hold
14,230
1.09% 16
2015
Q2
$1.39M Sell
14,230
-2,885
-17% -$289K 1.09% 15
2015
Q1
$1.72M Buy
+17,115
New +$1.74M 1.3% 14

Other funds holding JNJ

Bourne Lent Asset Management's JNJ Position: Q1 2026 in Review

Bourne Lent Asset Management increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, buying an estimated $34.9K and bringing the position to 14,206 shares worth $3.47M. The position accounts for 1.28% of the portfolio, ranked #18.

Bourne Lent Asset Management first reported a position in JNJ in Q1 2015 and has held it in 45 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bourne Lent Asset Management held 14,206 shares of Johnson & Johnson worth $3.47M as of Q1 2026.
  • Bourne Lent Asset Management bought 150 Johnson & Johnson shares in Q1 2026, an estimated $34.9K.
  • Johnson & Johnson made up 1.28% of Bourne Lent Asset Management's portfolio in Q1 2026, its #18 holding.
  • Bourne Lent Asset Management first reported a position in Johnson & Johnson in Q1 2015 and has held it in 45 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bourne Lent Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.